PDPL Intraday Analysis...

PDPL Share Price

Open 23.20 Change Price %
High 23.50 1 Day -0.40 -1.72
Low 22.25 1 Week -0.55 -2.35
Close 22.90 1 Month -1.25 -5.18
Volume 15233 1 Year -9.70 -29.75
52 Week High 36.00
52 Week Low 19.30
PDPL Important Levels
Resistance 2 24.06
Resistance 1 23.58
Pivot 22.88
Support 1 22.22
Support 2 21.74
NSE INDIA Most Active Stocks
JPASSOCIAT 18.75 14.33%
GMRINFRA 21.35 2.64%
RCOM 21.20 5.47%
IBREALEST 204.45 6.48%
FORTIS 172.50 -12.83%
SBIN 288.95 -1.88%
SUZLON 18.40 -1.60%
HDIL 85.85 -1.27%
DLF 192.05 -1.92%
ICICIBANK 291.85 0.78%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
SPYL 0.30 20.00%
KARMAENG 46.95 19.92%
ARCOTECH 96.65 19.32%
CIGNITITEC 303.35 14.75%
JPASSOCIAT 18.75 14.33%
SHRIRAMEPC 26.65 11.51%
TI 12.15 9.95%
TI 12.15 9.95%
SAMTEL 0.60 9.09%
More..
NSE INDIA Top Losers Stocks
RASOYPR 0.10 -33.33%
REIAGROLTD 0.30 -14.29%
FORTIS 172.50 -12.83%
SPCENET 0.40 -11.11%
NICCO 0.40 -11.11%
IFBAGRO 431.85 -8.20%
CASTEXTECH 7.90 -7.60%
NEXTMEDIA 20.15 -6.93%
ANKITMETAL 1.35 -6.90%
ESL 4.15 -6.74%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 4
As on 23rd Jun 2017 PDPL Share Price closed @ 22.90 and we RECOMMEND Sell for LONG-TERM with Stoploss of 26.22 & Strong Sell for SHORT-TERM with Stoploss of 25.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for June
1st Target up-side 25.64
2nd Target up-side 27.66
3rd Target up-side 29.69
1st Target down-side 19.86
2nd Target down-side 17.84
3rd Target down-side 15.81
PDPL Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) N/A N/A
RSI (14) RSI is 38.85 Sideways
MFI (14) MFI is 32.17 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 26.46
10 Day Avg Volume Traded 58.01 % More then 10 Day Average Volume
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.